Found 174 news articles for inflammation

Order by most

Recent Relevant
  • Using our immune system to fight COVID-19

    …older people. Our innate immune response provides early antiviral protection and shapes the immunity required later for vaccine responses. But, if uncontrolled, the resulting hyper-acute inflammation from excess cytokines can……  Read more

    Professor Paul Hertzog from the Regulation of Interferon and Innate Signalling Research Group at Hudson Institute
  • Inflammation and infectious diseases

    …that induces inflammation. Activated cells are identified in bright blue. COVID-19 has similar characteristics to severe Influenza A virus (IAV) infections, including the damaging lung inflammation that causes ARDS. Associate……  Read more

    Dr Michelle Tate and A/Prof Ashley Mansell from Centre for Innate Immunity and Infectious Diseases at Hudson Institute
  • Hyper-acute inflammation in COVID-19

    inflammation. How we are tackling acute inflammation Selection of molecules that can be quickly repurposed as anti-inflammatory drugs to prevent chronic inflammation and sepsis Development of new treatments that build……  Read more

    Dr Michael Gantier from the Nucleic Acids and Innate Immunity Research Group at Hudson Institute
  • Our response to COVID-19

    …to Influenza A virus (IAV), including damaging lung inflammation. Here macrophages engulf an IAV peptide that induces inflammation where activated cells are identified by bright blue ‘specks’. How you can……  Read more

  • Keeping stomach cancer at bay 

    …pylori). PhD researcher Michelle Chonwerawong identified a protein in immune cells, NLRC5, which regulates inflammation levels in the stomach after bacterial infection. Professor Richard Ferrero In this study, published online……  Read more

    Professor Richard Ferrero from the Gastrointestinal Infection and Inflammation Research Group at Hudson Institute
  • Simple blood test can improve ovarian cancer diagnosis

    …the disease.” The study used an immune marker for inflammation (IL-6) together with cancer markers to detect epithelial ovarian cancer in blood. Results were validated across two separate human trial……  Read more

    Dr Andrew Stephens from the Ovarian Cancer Biomarkers Research Group at Hudson Institute
  • Unearthing a new form of toxic inflammation

    Hudson Institute scientists have discovered how a molecule is transferred between damaged cells and healthy immune cells, which might cause toxic inflammation in a host of diseases. This toxic inflammation…  Read more

    Dr Michael Gantier from the Nucleic Acids and Innate Immunity Research Group at Hudson Institute
  • Strengthening international collaborations with the University of Toronto

    A two-day workshop is being held to promote collaborative research opportunities between cancer and inflammation researchers at Hudson Institute and the Department of Immunology at the University of Toronto. Following……  Read more

    Assistant Professor Sonya MacParland, Professor Elizabeth Hartland, Professor Juan Carlos Zuniga-Pflucker, Associate Professor David Brooks, Associate Professor Tracy McGaha, Assistant Professor Slava Epelman, Professor Paul Hertzog, Professor Eleanor Fish, Dr Kate Lawlor.
  • Paving the way towards a new anti-inflammatory agent

    …discovered, using both pre-clinical and in vitro models, that IL-37 inhibits inflammation by targeting multiple steps required for the production of proteins such as IL-1β, which promote inflammation in the……  Read more

    Dr Ina Rudloff, Postdoctoral Scientist in the Interventional Immunology in Early Life Diseases Research Group at Hudson Institute
  • Protecting growth-restricted babies from brain injury with stem cell therapy

    …neuroinflammation, oxidative stress, cerebrovascular resistance (obstruction to blood flow), and greater integrity of the neurovascular unit in the brain. The team believe that UCBCs stabilise the neurovascular unit—comprising of several……  Read more

    Professor Suzie Miller and Dr Atul Malhotra from the Neurodevelopment and Neuroprotection Research Group at Hudson Institute